Journal
CELL REPORTS
Volume 18, Issue 2, Pages 468-481Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2016.12.037
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81373428, 81673447, 81503088, 31471232]
- Natural Science Foundation of Guangdong Province [2014A030313156]
- Fundamental Research Funds for the Central Universities [13ykpy07]
- Joint Research Fund for Overseas Natural Science of China [3030901001222]
- Major Program of Science and Technology of Guangzhou [201607020001]
- Science and Technology Planning Projects of Guangdong Province [2014B030301040]
Ask authors/readers for more resources
Glioblastoma multiforme (GBM) is among the most aggressive of human cancers. Although differentiation therapy has been proposed as a potential approach to treat GBM, the mechanisms of induced differentiation remain poorly defined. Here, we established an induced differentiation model of GBM using cAMP activators that specifically directed GBM differentiation into astroglia. Transcriptomic and proteomic analyses revealed that oxidative phosphorylation and mitochondrial biogenesis are involved in induced differentiation of GBM. Dibutyryl cyclic AMP (dbcAMP) reverses the Warburg effect, as evidenced by increased oxygen consumption and reduced lactate production. Mitochondrial biogenesis induced by activation of the CREB-PGC1 alpha pathway triggers metabolic shift and differentiation. Blocking mitochondrial biogenesis using mdivi1 or by silencing PGC1 alpha abrogates differentiation; conversely, overexpression of PGC1 alpha elicits differentiation. In GBM xenograft models and patient-derived GBM samples, cAMP activators also induce tumor growth inhibition and differentiation. Our data show that mitochondrial biogenesis and metabolic switch to oxidative phosphorylation drive the differentiation of tumor cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available